Reports - Press Releases

Date	Title	Company
28-Jul-2025	GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer’s and Other Neurodegenerative Diseases	ACCESS Newswire
28-Jul-2025	Federal Mandates, Not Incentives, Drive Psychiatric Hospitals to Replace EHRs, Black Book Survey	ACCESS Newswire
28-Jul-2025	Moderna Announces Data to be Presented at ESMO Congress 2025	ACCESS Newswire
28-Jul-2025	How Biodexa Is Racing To Get Its Phase 3 Program in FAP Under Way And Gain First-Mover Advantage in a $7Bn Addressable Market	ACCESS Newswire
28-Jul-2025	Neurocare Expands Clinic Network in the Netherlands With Acquisition of Perinatal Mental Health Specialists, MeJa Psychologie	ACCESS Newswire
28-Jul-2025	Transgene and BioInvent to Present Updated Data on Armed Oncolytic virus BT-001 at ESMO 2025	ACCESS Newswire
27-Jul-2025	TEO Partners With MarketWell Nutrition to Launch Ovitage in North America - the World's Most Complete Collagen	ACCESS Newswire
27-Jul-2025	DEA Scrambles to Defend Marijuana Decision Amid Supreme Court Ruling, Legal Collapse And Public Outrage	ACCESS Newswire
26-Jul-2025	Age Guard: A Full-Spectrum Longevity Formula, Backed by Cellular Health Science	ACCESS Newswire
26-Jul-2025	Major Health Insurers Slash Prior Authorization Requirements, Transforming the PA Technology Landscape	ACCESS Newswire
25-Jul-2025	BioNxt Solutions Announces Closing of First Tranche of Convertible Debenture Unit Private Placement	ACCESS Newswire
25-Jul-2025	Grow Your Career at MCS as a CNC Swiss Lead Machinist and Sr. Manufacturing Engineer	ACCESS Newswire
25-Jul-2025	The Gene Editing Revolution: Transforming Healthcare Through Precision Genomics	MBI
25-Jul-2025	AbinoNutra(R) Unveils Advanced '5-in-1' Longevity Dietary Supplement Featuring FDA-GRAS Recognized Dr.Ergo(R) L-Ergothioneine	ACCESS Newswire
25-Jul-2025	EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-CoV-2 Variant LP.8.1	ACCESS Newswire
25-Jul-2025	Wellgistics Health Converts $8.1M Debt to Equity	ACCESS Newswire
25-Jul-2025	Alligator Bioscience Announces Upcoming Presentation of REACtiVe-2 Phase 1 Data at ESMO Congress 2025	ACCESS Newswire
25-Jul-2025	Forecasting The Therapeutic Drug Monitoring Market: A CAGR Of 8.35% By 2035	Market Reports
25-Jul-2025	Biovica Launches DiviTum(R) TKa for Use in Early Breast Cancer	ACCESS Newswire
24-Jul-2025	Primus Sounds Alarm on Chronic Venous Insufficiency as President Trump's Diagnosis Sparks National Focus	ACCESS Newswire